SCHEMBL25754096

SCHEMBL25754096

CCCCOc1ccc(C[C@H](NC(=O)CC2CCN(C(=O)OC(C)(C)C)CC2)C(=O)OC)cc1

nearest known ligand 0.79

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
YAP1 P46937 13/20 0.79
GPR119 Q8TDV5 5/20 0.50
ITGB1 P05556 1/20 0.48
ITGA4 P13612 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19982071 0.88 YAP1 (1.00) YAP1
SCHEMBL19982220 0.87 YAP1 (0.77) YAP1ITGB1ITGA4
SCHEMBL19982219 0.87 YAP1 (0.77) YAP1ITGB1ITGA4
SCHEMBL25754127 0.86 YAP1 (0.70) YAP1
SCHEMBL19982213 0.86 YAP1 (0.85) YAP1GPR119
SCHEMBL19982212 0.86 YAP1 (0.85) YAP1GPR119
SCHEMBL25754091 0.82 YAP1 (0.84) YAP1
SCHEMBL7280760 0.82 ITGB3 (0.62) YAP1GPR119
SCHEMBL25754121 0.81 YAP1 (0.69) YAP1
SCHEMBL25754120 0.81 YAP1 (0.71) YAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11685725-B2 YAP1 inhibitors that target the interaction of YAP1 with OCT4 H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. (US) 2023-06-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11685725-B2 YAP1 inhibitors that target the interaction of YAP1 with OCT4 YAP1, YES1, MYC YAP1 1/4885GPR119 2981/4885ITGB1 4135/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.